A61K 39/13
Poliovirus
A61K39/13 (Poliovirus) appears on 102 US grants and 177 published applications in this corpus.
Search patents in A61K- Granted patents
- 102
- Published applications
- 177
- Assignees
- 108
- Inventors
- 366
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 5 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 4 |
| 2004 | 2 | 3 |
| 2005 | 0 | 3 |
| 2006 | 1 | 5 |
| 2007 | 2 | 2 |
| 2008 | 1 | 4 |
| 2009 | 0 | 2 |
| 2010 | 1 | 12 |
| 2011 | 2 | 8 |
| 2012 | 0 | 3 |
| 2013 | 5 | 9 |
| 2014 | 3 | 12 |
| 2015 | 4 | 14 |
| 2016 | 7 | 10 |
| 2017 | 4 | 9 |
| 2018 | 13 | 7 |
| 2019 | 10 | 14 |
| 2020 | 7 | 10 |
| 2021 | 4 | 13 |
| 2022 | 4 | 7 |
| 2023 | 3 | 7 |
| 2024 | 6 | 10 |
| 2025 | 2 | 4 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Liquid six combined vaccine composition8 Apr 2025US 12,268,738 B2KM Biologics Co., Ltd.
- Methods for the prophylaxis and treatment of COVID and COVID-194 Mar 2025US 12,239,629 B2
- Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer31 Dec 2024US 12,178,869 B2Codagenix Inc.
- Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same17 Sep 2024US 12,090,195 B2Serum Institute of India Private Limited
- Irradiation-inactivated poliovirus, compositions including the same, and methods of preparation23 Jul 2024US 12,042,533 B2Biological Mimetics, Inc.
- Differential coating of microprojections and microneedles on arrays8 Oct 2026US 2026/0306611 A1Vaxxas Pty Limited
- Nucleic acid-lipid nanoparticle composition, and lyophilized preparation thereof, preparation method therefor and use thereof1 Oct 2026US 2026/0294829 A1Cansino Biologics Inc.
- Compositions, methods, and uses for polynucleotide formulations for drying and prolonged storage15 Jan 2026US 2026/0014251 A1VitriVax, Inc.
- Methods for the prophylaxis and treatment of covid and covid-1916 Oct 2025US 2025/0319060 A1
- Salmonella free egg production methods and systems19 Jun 2025US 2025/0195635 A1Luberski Inc. (Dba Hidden Villa Ranch)
Most cited
By later US patents
- Method for processing and preserving collagen-based tissues for transplantation610US 5,336,616 ALifeCell Corporation · 1994
- Method of cryopreserving a suspension of biological material150US 5,364,756 ALifeCell Corporation · 1994
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions90US 5,780,295 ALife Cell Corporation · 1998
- Acellular dermal matrix and method of use thereof for grafting75US 8,067,149 B2LifeCell Corporation · 2011